Working… Menu

Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02995993
Recruitment Status : Completed
First Posted : December 19, 2016
Last Update Posted : December 13, 2017
FGK Clinical Research GmbH
Information provided by (Responsible Party):
Greenovation Biotech GmbH